论文部分内容阅读
200904 Fos、Jun、Rb、p16和bcl-2蛋白在食管癌的表达及其意义/吴名耀…//河南肿瘤学杂志.-1999,12(6).441～443 用免疫组化SABC法,观察42例食管癌组织和5例切缘食管粘膜中Fos、Jun、Rb、p16和bcl-2蛋白的表达。结果,全组食管癌组织中Fos、Jun、Rb、p16和bcl-2阳性检出率分别为59.5%、50.0%、85.7%、64.3%、38.1%,其阳性表达率分别与食管癌的分化程度和淋巴结转移关系密切(P<0.05)。认为多种癌基因蛋白均参与食管癌的发生与发展过程,各有不同的生物学作用。联合检测这些蛋白有助于了解食管癌患者预后。表3参10(阮萃才) 200905 食管癌患者血清VEGF水平及其临床意义/李健…//中国肿瘤临床与康复。-1999,6(6).-42～43,41
200904 Expression of Fos, Jun, Rb, p16 and bcl-2 Proteins in Esophageal Carcinoma and Its Significance/ Wu Mingyao... // Henan Journal of Oncology.-1999, 12(6).441-443 Immunohistochemical SABC method, observation The expression of Fos, Jun, Rb, p16 and bcl-2 protein in esophageal mucosa of 42 cases of esophageal cancer tissue and 5 cases of resection margin. Results: The positive rates of Fos, Jun, Rb, p16, and bcl-2 in the whole group were 59.5%, 50.0%, 85.7%, 64.3%, and 38.1%, respectively, and their positive expression rates were different from those of esophageal cancer. The degree was closely related to lymph node metastasis (P<0.05). It is believed that many oncogene proteins are involved in the occurrence and development of esophageal cancer, each with different biological effects. Combined detection of these proteins helps to understand the prognosis of patients with esophageal cancer. Table 3 Shen 10 (Cui Cuicai) 200905 Serum VEGF levels in patients with esophageal cancer and its clinical significance / Li Jian ... / / Chinese Oncology Clinical and Rehabilitation. -1999,6(6).-42~43,41